Oklahoma City, OK – In a groundbreaking discovery that redefines our understanding of cancer progression, new research...
California-based biopharma company Alumis is poised to launch a significant challenge in the highly competitive oral psoriasis...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-Like Peptide-1 (GLP-1)...
The campaign arrives at a critical juncture in oncology. While advancements in screening have improved survival rates...
The landscape of oncology is undergoing a transformative shift as the U.S. Food and Drug Administration (FDA)...
TORONTO, ON — As the medical community continues to make strides in early detection and acute treatment...
Executive Summary: A Strategic Partnership for Global Health The Director-General of the World Health Organization (WHO), Dr....
The biotechnology sector is currently navigating a period of intense scrutiny and rapid evolution. From the reassessment...
The high-stakes world of cardiac electrophysiology has entered a new phase of legal turbulence as Boston Scientific...
In the landscape of modern drug discovery, the traditional animal study has long been viewed as a...
